From: Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer
Clinical characteristic | Patients (n) | EPCs (per ml) | P |
---|---|---|---|
Age | Â | Â | NS |
   <43 years old | 17 | 1154 ± 93.7 |  |
   ≥43 years old | 25 | 1205 ± 178.5 |  |
Residual tumor size | Â | Â | 0.029 |
   <2 cm | 22 | 523 ± 92.6 |  |
   ≥2 cm | 8 | 875 ± 192.6 |  |
FIGO stage | Â | Â | 0.034 |
   I--II | 8 | 1023 ± 104.2 |  |
   III--IV | 34 | 1450 ± 206.5 |  |
Histological subtype | Â | Â | NS |
   Serous | 23 | 1165 ± 254.6 |  |
   Mucinous | 13 | 1187 ± 223.7 |  |
   Endometrioid | 6 | 1235 ± 198.4 |  |
Therapy | Â | Â | NS |
   Chemotherapy | 12 | 783.4 ± 162.5 |  |
   Surgery | 30 | 605 ± 147.2 |  |